Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 influenza season
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
This report updates the 2019-20 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2019;68[No. RR-3]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. Inactivated influenza vaccines (IIVs), recombinant influenza vaccine (RIV4), and live attenuated influenza vaccine (LAIV4) are expected to be available. Most influenza vaccines available for the 2020-21 season will be quadrivalent, with the exception of MF59-adjuvanted IIV, which is expected to be available in both quadrivalent and trivalent formulations.Updates to the recommendations described in this report reflect discussions during public meetings of ACIP held on October 23, 2019; February 26, 2020; and June 24, 2020. Primary updates to this report include the following two items. First, the composition of 2020-21 U.S. influenza vaccines includes updates to the influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B/Victoria lineage components. Second, recent licensures of two new influenza vaccines, Fluzone High-Dose Quadrivalent and Fluad Quadrivalent, are discussed. Both new vaccines are licensed for persons aged ≥65 years. Additional changes include updated discussion of contraindications and precautions to influenza vaccination and the accompanying Table, updated discussion concerning use of LAIV4 in the setting of influenza antiviral medication use, and updated recommendations concerning vaccination of persons with egg allergy who receive either cell culture-based IIV4 (ccIIV4) or RIV4.The 2020-21 influenza season will coincide with the continued or recurrent circulation of SARS-CoV-2 (the novel coronavirus associated with coronavirus disease 2019 [COVID-19]). Influenza vaccination of persons aged ≥6 months to reduce prevalence of illness caused by influenza will reduce symptoms that might be confused with those of COVID-19. Prevention of and reduction in the severity of influenza illness and reduction of outpatient illnesses, hospitalizations, and intensive care unit admissions through influenza vaccination also could alleviate stress on the U.S. health care system. Guidance for vaccine planning during the pandemic is available at https://www.cdc.gov/vaccines/pandemic-guidance/index.html.This report focuses on recommendations for the use of vaccines for the prevention and control of seasonal influenza during the 2020-21 season in the United States. A brief summary of the recommendations and a link to the most recent Background Document containing additional information are available at https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html. These recommendations apply to U.S.-licensed influenza vaccines used within Food and Drug Administration (FDA)-licensed indications. Updates and other information are available from CDC's influenza website (https://www.cdc.gov/flu). Vaccination and health care providers should check this site periodically for additional information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“From placebo-controlled clinical trial data, there is no evidence of increased calcitonin or C-cell neoplasia in humans”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1811]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Self-citationFiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,088
Self-citationGrohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Self-citationPandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
Self-citation(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876 · cited 1×
“Fluzone High-Dose (HD-IIV3) met prespecified criteria for superior efficacy against laboratory-confirmed influenza compared with that of standard-dose Fluzone (SD-IIV3) in a randomized trial conducted over two seasons (2011–12 and 2012–13) among 31,989 persons aged ≥65 years (53,60,61).”
BackgroundThe Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
Pearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
Patel, A., Jernigan, D. B., 2019-nCoV CDC Response Team, 2019-nCoV CDC Response Team, Abdirizak, F., Abedi, G., Aggarwal, S., Albina, D., Allen, E., Andersen, L., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6905e1 · Cited by 449
Self-citation(2011) · PubMed · Cited by 424
Grohskopf, L. A., Alyanak, E., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2019) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6803a1 · Cited by 393
Self-citationFalsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388 · cited 8×
“A meta-analysis reported that HD-IIV3 provided better protection than SD-IIV3 against ILI (relative VE = 19.5%; 95% CI: 8.6%–29.0%); all-cause hospitalizations (relative VE = 9.1%; 95% CI: 2.4%–15.3%); and hospitalizations due to influenza (relative VE = 17.8%; 95% CI: 8.1%–26.5%), pneumonia (relative VE = 24.3%; 95%…”
BackgroundInfluentialIMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Rolfes, M. A., Foppa, I. M., Garg, S., Flannery, B., Brammer, L., Singleton, J. A., Burns, E., Jernigan, D., Olsen, S. J., Bresee, J., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12486 · Cited by 310
Self-citationEffects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 297
Self-citationEfficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608862 · Cited by 291
Barker, W. H. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.761 · Cited by 290
Influenza- and RSV-associated hospitalizations among adults
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, L. A., Black, S., & Shay, D. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.041 · Cited by 235
Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J. G., Flannery, B., Jackson, M. L., & Belongia, E. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw816 · Cited by 195
Self-citationKissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Neuzil, K. M., Jackson, L. A., Nelson, J., Klimov, A., Cox, N., Bridges, C. B., Dunn, J., DeStefano, F., & Shay, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/507309 · Cited by 191
The Burden of Influenza in Young Children, 2004–2009
Poehling, K. A., Edwards, K. M., Griffin, M. R., Szilagyi, P. G., Staat, M. A., Iwane, M. K., Snively, B. M., Suerken, C. K., Hall, C. B., Weinberg, G. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1255 · Cited by 183
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Izurieta, H. S., Thadani, N., Shay, D. K., Lu, Y., Maurer, A., Foppa, I. M., Franks, R., Pratt, D., Forshee, R. A., MaCurdy, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71087-4 · Cited by 181
Gravenstein, S., Davidson, H. E., Taljaard, M., Ogarek, J., Gozalo, P., Han, L., & Mor, V. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30235-7 · Cited by 176
Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
Mannino, S., Villa, M., Apolone, G., Weiss, N. S., Groth, N., Aquino, I., Boldori, L., Caramaschi, F., Gattinoni, A., Malchiodi, G., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws313 · Cited by 171
Pebody, R. G., Andrews, N., McMenamin, J., Durnall, H., Ellis, J., Thompson, C. I., Robertson, C., Cottrell, S., Smyth, B., Zambon, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20389-en · Cited by 163
Van Buynder, P. G., Konrad, S., Van Buynder, J. L., Brodkin, E., Krajden, M., Ramler, G., & Bigham, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.059 · Cited by 160
Castilla, J., Martínez-Baz, I., Martínez-Artola, V, Reina, G., Pozo, F., García Cenoz, M., Guevara, M., Moran, J., Irisarri, F., Arriazu, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20388-en · Cited by 156
McMillan, M., Porritt, K. A., Kralik, D., Costi, L., & Marshall, H. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.068 · Cited by 155
Belongia, E. A., Sundaram, M. E., McClure, D. L., Meece, J. K., Ferdinands, J. M., & VanWormer, J. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.052 · Cited by 152
Lee, J. K. H., Lam, G., Shin, T., Kim, J., Krishnan, A., Greenberg, D. P., & Chit, A. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1471989 · Cited by 149
Coleman, B. L., Fadel, S. A., Fitzpatrick, T., & Thomas, S.-M. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12504 · Cited by 145
Bratton, K. N., Wardle, M. T., Orenstein, W. A., & Omer, S. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu915 · Cited by 143
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
Mutsch, M., Tavernini, M., Marx, A., Gregory, V., Lin, Y. P., Hay, A. J., Tschopp, A., & Steffen, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429243 · Cited by 137
Patterson, J. L., Randle, S. C., Hageman, J. R., & Kelley, K. R. (2013) · Pediatric Annals · doi:10.3928/00904481-20131122-09 · Cited by 137
Eisenberg, K. W., Szilagyi, P. G., Fairbrother, G., Griffin, M. R., Staat, M., Shone, L. P., Weinberg, G. A., Hall, C. B., Poehling, K. A., Edwards, K. M., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-3304 · Cited by 131
DiazGranados, C. A., Robertson, C. A., Talbot, H. K., Landolfi, V. A., Dunning, A. J., & Greenberg, D. P. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.006 · Cited by 130
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Allison, M. A., Daley, M. F., Crane, L. A., Barrow, J. C., Beaty, B. L., Allred, N. J., Berman, S., & Kempe, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.036 · Cited by 130
Kissling, E., Nunes, B., Robertson, C., Valenciano, M., Reuss, A., Larrauri, A., Cohen, J. M., Oroszi, B., Rizzo, C., Machado, A., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.16.30201 · Cited by 127
Pasternak, B., Svanstrom, H., Molgaard-Nielsen, D., Krause, T. G., Emborg, H.-D., Melbye, M., & Hviid, A. (2012) · BMJ · doi:10.1136/bmj.e2794 · Cited by 121
Intraseason Waning of Influenza Vaccine Effectiveness
Ray, G. T., Lewis, N., Klein, N. P., Daley, M. F., Wang, S. V., Kulldorff, M., & Fireman, B. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy770 · Cited by 118
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., Weintraub, E., Vazquez‐Benitez, G., McNeil, M. M., Li, R., Klein, N. P., Hambidge, S. J., Naleway, A. L., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001066 · Cited by 117
Chambers, C., Johnson, D., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.097 · Cited by 115
ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002588 · Cited by 115
Donahue, J. G., Kieke, B. A., King, J. P., Destefano, F. R., Mascola, M. A., Irving, S. A., Cheetham, T. C., Glanz, J. M., Jackson, L. A., Klein, N. P., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.069 · Cited by 113
Shay, D. K., Chillarige, Y., Kelman, J. A., Forshee, R. A., Foppa, I., Wernecke, M., Lu, Y., Ferdinands, J. M., Iyengar, A., Fry, A. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw641 · Cited by 108
Self-citationSafety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
Heikkinen, T., Young, J., van Beek, E., Franke, H. R., Verstraeten, T., Weil, J., & Cioppa, G. D. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.007 · Cited by 104
Kerzner, B., Murray, A. V., Cheng, E., Ifle, R., Harvey, P. R., Tomlinson, M., Barben, J. L., Rarrick, K., Stek, J. E., Chung, M., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01397.x · Cited by 96
DiazGranados, C. A., Dunning, A. J., Robertson, C. A., Talbot, H. K., Landolfi, V. A., & Greenberg, D. P. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.003 · Cited by 96
Schwarz, T. F., Flamaing, J., Rümke, H. C., Penzes, J., Juergens, C., Wenz, A., Jayawardene, D., Giardina, P., Emini, E. A., Gruber, W. C., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.031 · Cited by 94
Maternal Immunization: ACOG Committee Opinion, Number 741
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002662 · Cited by 93
Schwarz, T. F., Aggarwal, N., Moeckesch, B., Schenkenberger, I., Claeys, C., Douha, M., Godeaux, O., Grupping, K., Heineman, T. C., López‐Fauqued, M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix481 · Cited by 90
Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion
Irving, S. A., Kieke, B. A., Donahue, J. G., Mascola, M. A., Baggs, J., DeStefano, F., Cheetham, T. C., Jackson, L. A., Naleway, A. L., Glanz, J. M., et al. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318279f56f · Cited by 89
Nolan, T. M., Richmond, P., Formica, N. T., Höschler, K., SKELJO, M. V., Stoney, T., McVernon, J., Härtel, G., Sawlwin, D. C., Bennet, J. K., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.046 · Cited by 89
A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy
Oppermann, M., Fritzsche, J., Weber‐Schoendorfer, C., Keller‐Stanislawski, B., Allignol, A., Meister, R., & Schaefer, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.081 · Cited by 84
Fragaszy, E., Warren‐Gash, C., White, P. J., Zambon, M. C. F. A., Edmunds, W. J., Nguyen‐Van‐Tam, J. S., Hayward, A. C., & on behalf of the Flu Watch Group (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12506 · Cited by 83
Chambers, C., Johnson, D. L., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.054 · Cited by 81
Chang, L.-J., Meng, Y., Janosczyk, H., Landolfi, V. A., & Talbot, H. K. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.016 · Cited by 80
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months
Duffy, J., Weintraub, E., Hambidge, S. J., Jackson, L. A., Kharbanda, E. O., Klein, N. P., Lee, G. M., Marcy, S. M., Nakasato, C. C., Naleway, A., et al. (2016) · Pediatrics · doi:10.1542/peds.2016-0320 · Cited by 77
Large Summertime Influenza A Outbreak among Tourists in Alaska and the Yukon Territory
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K., Buxton, J. A., Miller, J. M., Beller, M. J., Butler, J. C., Fukuda, K., Maloney, S. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374053 · Cited by 76
Young‐Xu, Y., van Aalst, R., Mahmud, S. M., Rothman, K. J., Snider, J. T., Westreich, D. J., Mor, V., Gravenstein, S., Lee, J. K. H., Thommes, E. W., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy088 · Cited by 75
Frenck, R. W., Gurtman, A., Rubino, J., Smith, W., van Cleeff, M., Jayawardene, D. A., Giardina, P. C., Emini, E. A., Gruber, W. C., Scott, D. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00176-12 · Cited by 73
Lum, L. C. S., Borja-Tabora, C., Breiman, R. F., Vesikari, T., Sablan, B. P., Chay, O. M., Tantracheewathorn, T., Schmitt, H.-J., Lau, Y., Bowonkiratikachorn, P., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.054 · Cited by 70
Richardson, D. M., Medvedeva, E. L., Roberts, C. B., & Linkin, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ261 · Cited by 68
Petrie, J. G., Ohmit, S. E., Truscon, R., Johnson, E., Braun, T., Levine, M. Z., Eichelberger, M. C., & Monto, A. S. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw105 · Cited by 67
Donahue, J. G., Kieke, B. A., King, J. P., Mascola, M. A., Shimabukuro, T. T., DeStefano, F., Hanson, K. E., McClure, D. L., Olaiya, O., Glanz, J. M., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.035 · Cited by 59 · cited 1×
“However, in a larger VSD follow-up study, IIV was not associated with an increased risk for spontaneous abortion during the 2012–13, 2013–14, and 2014–15 seasons, regardless of previous season vaccination (52).”
BackgroundThe impact of influenza infection on young children, their family and the health care system
Willis, G. A., Preen, D. B., Richmond, P., Jacoby, P. A., Effler, P. V., Smith, D. W., Robins, C., Borland, M. L., Levy, A., Keil, A. D., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12604 · Cited by 59
Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
Puig-Barberà, J., Mira-Iglesias, A., Tortajada-Girbés, M., López-Labrador, F. X., Librero-López, J., Díez-Domingo, J., Carballido-Fernández, M., Carratalá-Munuera, C., Correcher-Medina, P., Gil-Guillén, V., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.035 · Cited by 58
Stockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 57
Self-citationRadin, J. M., Hawksworth, A. W., Myers, C. A., Ricketts, M. N., Hansen, E. A., & Brice, G. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.034 · Cited by 55
Ferdinands, J. M., Alyanak, E., Reed, C., & Fry, A. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz452 · Cited by 55
Self-citationInfluenza and Workplace Productivity Loss in Working Adults
Wormer, J. J. V., King, J. P., Gajewski, A., McLean, H. Q., & Belongia, E. A. (2017) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001120 · Cited by 54
Sammon, C., Snowball, J. M., McGrogan, A., & de Vries, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051734 · Cited by 52
Lapi, F., Marconi, E., Simonetti, M., Baldo, V., Rossi, A., Sessa, A., & Cricelli, C. A. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1622418 · Cited by 49
Millman, A. J., Duong, K. K., Lafond, K. E., Green, N. M., Lippold, S. A., & Jhung, M. A. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12215 · Cited by 47
Li, R., Stewart, B., McNeil, M. M., Duffy, J., Nelson, J. C., Kawai, A. T., Baxter, R. P., Belongia, E. A., & Weintraub, E. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3996 · Cited by 45
Essink, B. J., Fierro, C. A., Rosen, J., Figueroa, A. L., Zhang, B., Verhoeven, C., Edelman, J. M., & Smolenov, I. V. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.021 · Cited by 44
Ratnam, I., Black, J., Leder, K. S., Biggs, B., Gordon, I., Matchett, E., Padiglione, A. A., Woolley, I. J., Karapanagiotidis, T., Gherardin, T., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.01.008 · Cited by 40
Song, J. Y., Cheong, H. J., Tsai, T. F., Chang, H.-A., Choi, M. J., Jeon, J. H., Kang, S. H., Jeong, E. J., Noh, J. Y., & Kim, W. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.003 · Cited by 34
McNeil, S., Noya, F., Dionne, M., Predy, G., Meekison, W., Ojah, C., Ferro, S., Mills, E. L., Langley, J. M., & Halperin, S. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.047 · Cited by 31
Huang, W., Tang, F.-W., Yang, S.-E., Chih, Y.-C., & Chuang, J.-H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.054 · Cited by 31
Levin, M. J., Buchwald, U. K., Gardner, J. E., Martin, J. C., Stek, J. E., Brown, E., & Popmihajlov, Z. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.029 · Cited by 27
Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women
Ma, F., Zhang, L., Jiang, R., Zhang, J., Wang, H., Gao, X., Li, X., & Liu, Y. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00375-14 · Cited by 24
Nakashima, K., Aoshima, M., Ohfuji, S., Yamawaki, S., Nemoto, M., Hasegawa, S., Noma, S., Misawa, M., Hosokawa, N., Yaegashi, M., et al. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1455476 · Cited by 20
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations
Walter, E. B., Klein, N. P., Wodi, A. P., Rountree, W., Todd, C. A., Wiesner, A., Duffy, J., Marquez, P., & Broder, K. R. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1909 · Cited by 19
Self-citation
Research works printed but not linked: 3
- Food and Drug Administration. Clinical review: Fluad. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2015.
- Food and Drug Administration. Clinical review: Fluzone high-dose. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2014.
- Food and Drug Administration. Clinical review: Fluad Quadrivalent. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020.
Cited by
Olsen, S. J., Winn, A. K., Budd, A. P., Prill, M. M., Steel, J., Midgley, C. M., Kniss, K., Burns, E., Rowe, T., Foust, A., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7029a1 · Cited by 600
Self-citationOlsen, S. J., Azziz-Baumgartner, E., Budd, A. P., Brammer, L., Sullivan, S., Pineda, R. F., Cohen, C., & Fry, A. M. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6937a6 · Cited by 579
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab052 · Cited by 480
Grohskopf, L. A., Alyanak, E., Ferdinands, J. M., Broder, K. R., Blanton, L. H., Talbot, H. K., & Fry, A. M. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7005a1 · Cited by 360
Self-citation
Metadata
- Authors
- Grohskopf, L. A., Alyanak, E., Broder, K. R., Blanton, L. H., Fry, A. M., Jernigan, D. B., & Atmar, R. L.
- Affiliations
- National Center for Immunization and Respiratory Diseases (US)
- Battelle (US)
- Centers for Disease Control and Prevention (US)
- Baylor College of Medicine (US)
- Corresponding author
- Grohskopf, Lisa A.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2020-08-21
- Volume
- 69
- Issue
- 8
- Pages
- 1-24
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC7439976
- OpenAlex
- W4211031111
- Cited by
- 332
- References
- 88
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 33 · 2023: 42 · 2022: 92 · 2021: 107 · 2020: 25
- FWCI
- 47.63
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- seasonal influenza vaccination, influenza vaccine recommendations, inactivated influenza vaccine, live attenuated influenza vaccine, recombinant influenza vaccine, quadrivalent influenza vaccine, egg allergy, COVID-19 pandemic
- MeSH terms
- Adolescent, Adult, Aged, Centers for Disease Control and Prevention, U.S., Child, Child, Preschool, Female, Humans, Immunization Schedule, Infant, Influenza, Human, Influenza Vaccines, Male, Middle Aged, Influenza B virus, Pregnancy, Seasons, United States, Vaccines, Attenuated, Randomized Controlled Trials as Topic, Risk Assessment, Advisory Committees, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.